Haldwani, India

Nirmal Khati

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2019.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nirmal Khati: Innovator in Pharmaceutical Compositions

Introduction

Nirmal Khati is a notable inventor based in Haldwani, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compositions that incorporate boronic acid compounds. His work is essential in advancing medical treatments and improving patient outcomes.

Latest Patents

Nirmal Khati holds a patent for a pharmaceutical composition that comprises bortezomib or its pharmaceutically acceptable salt or solvate, tromethamine, and an organic carboxylic acid. The pH of this composition is maintained between about 3.0 to 6.0. This invention is crucial for enhancing the efficacy of treatments involving bortezomib, a drug used in cancer therapy.

Career Highlights

Nirmal Khati is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality in healthcare. His role at the company allows him to contribute to the development of new and effective pharmaceutical solutions.

Collaborations

Nirmal has collaborated with talented coworkers such as Navin Vaya and Harshal Prabhakar Bhagwatwar. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical innovations.

Conclusion

Nirmal Khati's contributions to pharmaceutical compositions highlight his role as an innovator in the industry. His patent and work at Dr. Reddy's Laboratories demonstrate his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…